Bookimed does not add extra charges for Immunotherapy prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Immunotherapy upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
| The USA | Turkey | Mexico | |
| Sarcoma Immunotherapy | from $10800 | from $3600 | from $4140 |
| Immunotherapy for prostate cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for lung cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for kidney cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for breast cancer | from $30000 | from $10000 | from $11500 |
SJD Barcelona Children's Hospital ranks among the Top-5 medical institutions in Europe. It was recognized as the most authoritative for pediatric oncology treatment. The hospital is accredited by the National Board of Health in Spain and the National Association of Children’s Hospitals and Related Institutions. The immunotherapy anti-GD2 drug for neuroblastoma treatment increases the survival rate by 20%. Patients can visit nearby attractions like the famous Park Güell or Sagrada Familia during their stay.
Hospital Quirón Barcelona is recognized for its expertise in oncology care, collaborating with leading American centers. It holds Joint Commission International accreditation, ensuring high standards in medical services. The Baselga Institute of Oncology specializes in fields like haemato-oncology and neurooncology. The hospital has 23 operating rooms and advanced technology, including PET-CT. It offers personalized care, competitive pricing, and amenities for international patients. Nearby attractions include the stunning Sagrada Familia, providing a cultural experience during your stay.
Hospital HM Nou Delfos is part of Spain's largest network, HM Hospitals. The clinic holds accreditations from the European Foundation for Quality Management and ISO 9001 by TÜV NORD CERT. HM Nou Delfos specializes in oncology and offers high-precision CT and MRI diagnostic tools. Patients can also explore nearby Barcelona attractions, such as Park Güell and Sagrada Família. The clinic's collaboration with Institut Guttmann ensures top-quality neurorehabilitation services.
The therapy is a treatment enhancing the body"s immune system to fight cancer, using a drug highly targeted and effective.
This therapy modifies patient"s cells to combat cancer, merging immunology and genetics. It"s precise, powerful, potentially one-off treatment.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
What patients like:
What patients don't like:
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.
Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.
Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.